Spur is advancing a breakthrough gene therapy candidate for Gaucher disease, a potential first-in-class gene therapy candidate for adrenomyeloneuropathy and a preclinical gene therapy candidate ...
Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...
A stretch of the A3 in Surrey has reopened following a weekend closure to install a pedestrian bridge. The closure, between junction 10 of the M25 and the A247 near Send, was in both directions ...
High blood pressure affects multiple organs. Not only can hypertension add stress to the heart and damage arteries, leading to heart disease, but it also can cause strokes and kidney disease as ...
Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, ...
Video: Broad Institute of MIT and Harvard At a glance: Study explains long-standing question of why Huntington’s disease symptoms typically do not appear until midlife even though patients are born ...
in 2023 (PMID: 35986643). Figure 2. PET scan images showing presence of target enzyme dCK in a normal mouse (left), and one with Crohn’s disease (right). Sources: NEnglJMed.2020 Dec 31;383(27 ...
announces an upcoming poster presentation at the Crohn’s & Colitis Congress (CCC) Annual Meeting. Drs. Peter M. Clark, of the University of California Los Angeles, and Kenneth A. Schultz ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback